|
Highlights from the
| Deadline Alert! David Epstein Clinician-Scientist Award Applications are due no later than December 16, 2023 In their continuing commitment to encourage Fellow research, CGGS created the David Epstein Clinician-Scientist Research Award. A research grant of will be awarded to the chosen recipient's institution. This research award honors David L. Epstein, MD who is widely considered to be one of the most influential leaders in the world of glaucoma and glaucoma research over the past 40 years. The award was created to honor his commitment to the scientific understanding and cure of glaucoma through the support of promising clinician-scientists in research environments. Review award criteria and download the Application.
David L. Epstein, MD |
| Annual Meeting Highlights Chandler Grant Glaucoma Society members gathered in record numbers (70 guests) to attend the Annual Meeting, held March 3, 2023 in Austin, Texas. III Forks provide a chic, yet casual setting for members to reconnect and socialize for the evening events. Joel Schuman, MD, FACS, Past President and Board member, kicked off the evening with a toast to Dr. W. Morton Grant and Dr. Paul A. Chandler, the society's namesake. He moderated several interesting case discussions, wiith numerous attendees commenting. The business meeting included remarks from incoming President, Joshua Stein, MD, MS. The membership unanimously confirmed Peter A. Netland, MD, PhD as President-Elect. Dr. Stein thanked outgoing president Janey Wiggs, MD, PhD for her leadership and dedication to the organization. |
IN THE NEWS |
ALCON (formerly Aerie Pharmaceuticals) COMMITS TO FIVE-YEAR GRANT TO FUND AWARD
The award is a small way to honor his commitment to the scientific understanding and cure of glaucoma through the support of promising clinician-scientists in research environments. As Joel Schuman, MD, past-president, CGGS, once wrote in a tribute to Dr. Epstein, his “greatest legacy is the army of clinician-scientists whom he inspired throughout his years.” | SUMMER NEWSLETTER
|
.png){kind=small}
The Chandler Grant Glaucoma Society (CGGS) is pleased to announce an exclusive five-year partnership with Aerie Pharmaceuticals, Inc., to fund the distinguished David L. Epstein Clinician-Scientist Research Award.
Learn About GlaucomaGlaucoma is an eye disease that has been called the "sneak thief of sight" because permanent damage to the eye can occur before patient even notices symptoms. That is why early detection and management of this chronic disease is so important. Information from the American Glaucoma Society - click here |
| THANK YOU TO ALCON FOR THEIR COMMITMENT TO SUPPORT THE DAVID L. EPSTEIN CLINICIAN-SCIENTIST RESEARCH AWARD |